Division of Nephrology, Department of Medicine, Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Ottawa Bioinformatics Core Facility, the Sprott Centre for Stem Cell Research, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Kidney Int. 2021 Sep;100(3):597-612. doi: 10.1016/j.kint.2021.05.034. Epub 2021 Jun 26.
Acute kidney injury (AKI) carries high morbidity and mortality, and effective treatments are lacking. Preclinical models support involvement of micro-RNAs (miRs) in AKI pathogenesis, although effects on the kidney transcriptome are unclear. We previously showed that injection of cord blood endothelial colony forming cell-derived exosomes, enriched in miR-486-5p, prevented ischemic AKI in mice. To further define this, we studied direct effects of miR-486-5p in mice with kidney ischemia-reperfusion injury. RNA-Seq was used to compare the impact of miR-486-5p and exosomes on the transcriptome of proximal tubules and kidney endothelial cells 24 hours after ischemia-reperfusion. In mice with AKI, injection of miR-486-5p mimic increased its levels in proximal tubules and endothelial cells, and improved plasma creatinine, histological injury, neutrophil infiltration, and apoptosis. Additionally, miR-486-5p inhibited expression of its target phosphatase and tensin homolog, and activated protein kinase B. In proximal tubules, miR-486-5p or exosomes reduced expression of genes associated with ischemic injury and the tumor necrosis factor (TNF) pathway, and altered distinct apoptotic genes. In endothelial cells, genes associated with metabolic processes were altered by miR-486-5p or exosomes, although TNF pathway genes were not affected. Thus, our results suggest that miR-486-5p may have therapeutic potential in AKI.
急性肾损伤(AKI)发病率和死亡率高,且缺乏有效的治疗方法。临床前模型支持 microRNAs(miRs)参与 AKI 的发病机制,尽管其对肾脏转录组的影响尚不清楚。我们之前的研究表明,注射富含 miR-486-5p 的脐带血内皮祖细胞衍生的外泌体可预防小鼠缺血性 AKI。为了进一步明确这一点,我们研究了 miR-486-5p 在肾缺血再灌注损伤小鼠中的直接作用。RNA-Seq 用于比较 miR-486-5p 和外泌体对缺血再灌注 24 小时后近端肾小管和肾脏内皮细胞转录组的影响。在 AKI 小鼠中,注射 miR-486-5p 模拟物可增加其在近端肾小管和内皮细胞中的水平,并改善血浆肌酐、组织学损伤、中性粒细胞浸润和细胞凋亡。此外,miR-486-5p 抑制其靶蛋白磷酸酶和张力蛋白同源物的表达,并激活蛋白激酶 B。在近端肾小管中,miR-486-5p 或外泌体减少与缺血损伤和肿瘤坏死因子(TNF)途径相关的基因表达,并改变不同的凋亡基因。在内皮细胞中,miR-486-5p 或外泌体改变与代谢过程相关的基因,但不影响 TNF 途径基因。因此,我们的研究结果表明,miR-486-5p 在 AKI 中可能具有治疗潜力。